10Dec/13

Positive Data on Infinity Pharma Candidate – Zacks.com

Positive Data on Infinity Pharma Candidate
Zacks.com
The study will evaluate the safety and efficacy of IPI-145 in iNHL patients whose disease is refractory to radioimmunotherapy or to both Roche/Biogen Idec Inc.’s (RHHBY)/(BIIB – Analyst Report) Rituxan (rituximab) and chemotherapy and who have 
Infinity Reports Updated Phase 1 Data of IPI-145 in Indolent Non-Hodgkin Business Wire (press release)
Infinity Reports Preclinical Data at ASH Annual Meeting in Diffuse Large B MarketWatch

all 25 news articles »

10Dec/13

Wider Statin Use Recommended for Chronic Kidney Disease – Monthly Prescribing Reference

Wider Statin Use Recommended for Chronic Kidney Disease
Monthly Prescribing Reference
For adults ≥50 years with an estimated glomerular filtration rate (eGFR) <60mL/min/1.73m&sup2;, not treated with chronic dialysis or kidney transplantation, treatment with a statin or statin/ezetimibe combination is recommended. Statin treatment is
CKD: KDIGO Guidelines Recommend Wider Use of StatinsMedscape

all 4 news articles »

10Dec/13

Wider statin use recommended for chronic kidney disease – Medical Xpress


Medscape

Wider statin use recommended for chronic kidney disease
Medical Xpress
(HealthDay)—New guidelines for lipid management in chronic kidney disease (CKD) recommend wider statin use, according to a clinical practice guideline published online Dec. 10 in the Annals of Internal Medicine. Marcello Tonelli, M.D., from the
CKD: KDIGO Guidelines Recommend Wider Use of StatinsMedscape
LDL No Longer Target of Kidney Disease Lipid ManagementMedPage Today

all 4 news articles »